-+ 0.00%
-+ 0.00%
-+ 0.00%

Kazia Therapeutics Reports Early Positive Responses for Paxalisib in Phase 1b Trial for Metastatic Triple-Negative Breast Cancer

Reuters·01/27/2026 17:41:47

Please log in to view news